ARCHIVES

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

DCBD Board Okays Recombinant DNA Diagnosis Concept, Two Others, But Rejects Three

June 3, 1983

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012

In Brief: Thomas Davis, Stanford Oncologist, Dead At 49; DeVita To Visit, NCI; Hunter Named WHI Liaison

September 4, 1992

Medicare Covers All PET Scans For Cancer In New Program

May 26, 2006

ACS Modifies Pap Test Guidelines

November 27, 1987

Bush Appoints Kripke To President’s Cancer Panel

March 21, 2003